Overview of Ferikind

Property	Description
Active Ingredients	Ferrous Ascorbate and Folic Acid
Pharmacological Class	Haematinic
Primary Formulations	Tablet, Suspension, Injection
Classification	Nutritional Supplement (Iron and Vitamin B9)
Origin	Synthesized Vitamin and Derived Mineral Salt

What is Ferikind and Its Pharmacological Class?

Ferikind is defined as a foundational haematinic combination product, classified pharmacologically as a Nutritional Supplement that delivers two micronutrients essential for robust blood formation. Iron and folic acid are recognized as haematinics for their role in stimulating the production of blood cells. This product, manufactured by Mankind Pharmaceuticals, is a specific combination of a synthesized B-vitamin (Folic Acid) and a derived mineral salt (Ferrous Ascorbate).

Its fundamental purpose is to replenish resources vital for the body's natural blood-making process, often positioning it as an agent for nutritional management in patient groups requiring increased intake. The medication is generally intended for Oral administration in forms such as Tablets and Suspensions, with specialized Parenteral preparations available to address critical needs.

Composition and Available Pharmaceutical Forms

Ferikind's core composition relies on the synergy between its two active ingredients: Ferrous Ascorbate (providing Elemental Iron) and Folic Acid (Vitamin B9). Iron is an essential mineral critical for the oxygen-carrying capacity of blood, while Folic Acid is a crucial water-soluble B-vitamin required for DNA synthesis and cell proliferation. Folic Acid is required for preventing common deficits.

Ferikind offers distinctive liquid oral options like Suspensions and Drops, which are particularly useful for pediatric patient groups or individuals who have difficulty swallowing tablets. The availability of multiple dosage forms ensures that this specific combination of ingredients can be delivered effectively across a varied patient population.

Regulatory References

National Institutes of Health (NIH)

What side effects are possible with Ferikind?

Possible side effects and safety information

The safety profile for this haematinic combination of ferrous ascorbate and folic acid is primarily characterized by effects linked to the administration of oral iron, as documented in official regulatory sources. These effects are classified and grouped according to standard System-Organ Classes (SOCs).

Adverse Reaction Classifications

Adverse reactions are most frequently classified as belonging to the Gastrointestinal Disorders SOC.

Classification	Effects Officially Documented
Common	Nausea, vomiting, abdominal discomfort, flatulence, constipation, or diarrhea.
Rare	Hypersensitivity reactions (allergic manifestations).

It is officially noted that gastrointestinal effects are frequently more apparent during the initial phase of treatment.

Significant Safety Constraints

Regulatory documentation highlights two critical areas for safety: serious toxicity and explicit limitations for use.

Serious Adverse Reactions: The most critical safety consideration is the mandatory warning concerning the risk of Acute Iron Poisoning/Toxicity, which is prominently highlighted in regulatory labels, particularly regarding accidental overdose in the pediatric population.

Restrictions for Use: Use is strictly restricted by regulatory Contraindications in individuals diagnosed with conditions involving iron overload, such as hemochromatosis. It is also restricted in cases of non-iron deficiency anemias (e.g., uncorrected Vitamin B12 deficiency), as the folic acid component may potentially obscure the underlying condition.

Other Official Safety Notes

The expected darkening or blackening of stools is documented as a known effect of oral iron and is included in safety information as it may interfere with the clinical assessment of gastrointestinal bleeding.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Ferikind (Ferrous Ascorbate and Folic Acid) is primarily defined by the acute toxicity of its elemental iron component. Regulatory documents classify iron overdosage as an acute emergency requiring urgent medical attention.

Documented Manifestations and Severe Outcomes

Initial overdose symptoms commonly include severe gastrointestinal distress such as Nausea, Vomiting, Diarrhea, Abdominal pain, and may escalate to bloody stools or vomiting blood. Systemic instability can present as Hypotension, Tachycardia, and severe lethargy, potentially progressing to Shock, Convulsions, Coma, and Acute Hepatic Failure.

Accidental overdose is a leading cause of fatal poisoning in children younger than 6 years.

Required Emergency Actions

If overdose is suspected, seek immediate medical attention or contact a Poison Control Center right away, as explicitly mandated by official labeling. If the individual collapses or has a seizure, call emergency services immediately.

In the event of acute toxicity, treatment protocols documented in regulatory sources list the use of the specific chelating agent Desferrioxamine and procedures such as gastric lavage or whole bowel irrigation. Monitoring typically includes continuous patient surveillance and repeated serum iron level checks.

Therapeutic Uses of Ferikind

Main Uses of Ferikind

Ferikind is primarily used to address iron deficiency and the associated condition known as iron deficiency anemia. This medication helps restore iron levels in the body when dietary intake is insufficient or when there is an increased physiological demand for this essential mineral.

Iron Deficiency Anemia

The most common application for Ferikind is the treatment of iron deficiency anemia. This condition occurs when the body lacks enough iron to produce sufficient hemoglobin, the protein in red blood cells that enables them to carry oxygen to tissues and organs. By providing a concentrated source of iron, Ferikind aids in the synthesis of hemoglobin and the production of healthy red blood cells.

Increased Iron Requirements

There are specific life stages and health conditions where the body's need for iron increases significantly. Ferikind may be used to meet these heightened demands in the following contexts:

Pregnancy and Lactation: During pregnancy, the volume of blood in the body increases, and iron is required for the development of the fetus and the placenta. Similarly, breastfeeding mothers may require supplemental iron to maintain their own health and support the infant.
Recovery from Blood Loss: Individuals who have experienced significant blood loss due to surgery, injury, or heavy menstrual cycles may use Ferikind to help replenish the body's iron stores.
Nutritional Deficiencies: In cases where the diet is chronically low in iron-rich foods, Ferikind serves to fill the nutritional gap and prevent the onset of anemia.

Benefits of Ferikind

By effectively increasing iron levels in the blood, Ferikind helps alleviate the symptoms associated with a lack of iron. The primary benefits of stabilizing iron levels include:

Reduced Fatigue: Improving oxygen transport throughout the body helps combat the persistent tiredness and lethargy often caused by anemia.
Improved Cognitive Function: Adequate oxygenation of the brain is necessary for concentration, memory, and mental clarity.
Support for Physical Performance: Higher iron levels can lead to improved physical stamina and reduced shortness of breath during exertion.
Enhanced Immune Function: Iron plays a role in maintaining a healthy immune system, and correcting a deficiency can help the body better defend itself against infections.

Eligibility and Restrictions for Use

Who Can and Cannot Use Ferikind? (Regulatory Eligibility)

Eligibility for Ferikind (Ferrous Ascorbate and Folic Acid) is strictly defined by regulatory authorities based on a patient's existing blood and iron status, life stage, and comorbidities.

Contraindicated Populations (Must Not Use)

Ferikind is strictly contraindicated in individuals with confirmed iron overload conditions, such as Haemochromatosis or Haemosiderosis. It is also prohibited for patients with untreated Vitamin B12 deficiency, as the Folic Acid component can mask the deficiency's hematologic symptoms, risking irreversible neurological damage. Use is prohibited in patients with non-iron deficiency anemias, including Haemolytic Anemia, where iron supplementation is inappropriate.

Conditional and Age-Related Use

Permitted Use is generally established for adults and is explicitly indicated for deficiency prevention and treatment during pregnancy and lactation. Conditional Use is required for patients with a history of inflammatory bowel disease or peptic ulcers, or those with severe hepatic or renal disorders. Furthermore, solid oral formulations are not recommended for young children under specific age thresholds, limiting pediatric eligibility for these forms.

What should I know about interactions with other medicines?

Ferikind Interactions with other medicines and products

Ferikind’s interaction profile is based on officially documented effects that influence the absorption of co-administered medicines and strict regulatory constraints.

Absorption-Based Interactions and Timing Rules

The iron component is officially documented to form complexes with and reduce the systemic exposure of several oral medications. This clinically significant pattern applies to specific antibiotic classes, including Quinolones and Tetracyclines, Thyroid Medications (such as Levothyroxine), and Levodopa.

To manage this effect, regulatory documents mandate mandatory timing separation for these medicines, as well as for Antacids and general food intake, which are also officially stated to reduce iron bioavailability. For example, co-administration with Antacids must be separated by at least two hours.

Pharmacodynamic Effects and Contraindications

Separately, the folic acid component is officially stated to interfere with the action of Hydantoin Anti-seizure Drugs, such as Phenytoin. Additionally, the product is strictly contraindicated for use in patients with undiagnosed Pernicious Anemia, a restriction necessary because folic acid may mask the hematologic symptoms of Vitamin B12 deficiency while neurological damage continues. Use is also contraindicated in conditions of iron overload (hemochromatosis).

Official Profile Summary

The overall regulatory profile is structured around managing absorption-related constraints to ensure predictable drug exposure and respecting strict contraindications for specific medical conditions.

Mechanism of Action

Ferikind contains Elemental Iron and Folic Acid, which function as necessary cofactors and substrates within biological pathways that regulate haemopoiesis.

Modulation of Erythropoiesis

This mechanism involves the direct assimilation of Iron, which serves as a crucial cofactor required for the synthesis of hemoglobin within erythroid precursor cells in the bone marrow. The subsequent integration of hemoglobin into erythrocytes facilitates the system-level physiological effect of oxygen carrying capacity.

Role in Cellular Proliferation

Folic Acid (Vitamin B9) is vital for the biosynthesis of purines and pyrimidines, the nucleotides required for DNA and RNA synthesis. By facilitating DNA production, Folic Acid is necessary for the cell division and terminal maturation of progenitor cell lines in the bone marrow. This pathway modulates the differentiation activity and resultant morphology of circulating erythrocytes.

Integration into Systemic Cofactor Pools

The formulation engages mechanisms that govern the incorporation of key elements into the body's reservoir systems. Absorbed Elemental Iron is integrated into systemic iron pools and stored primarily as ferritin in the liver and reticuloendothelial system. This modulation of systemic iron availability influences the subsequent metabolic processes that depend upon iron.

Dosage and Administration Information

Ferikind, a combination of Ferrous Ascorbate and Folic Acid, is administered following a structured protocol. The primary route of administration is Oral via tablets, such as the 100 mg/1.5 mg strength, or an oral suspension, such as the 30 mg/550 mcg per 5 mL strength. The Parenteral route (IV, IM, SC injection) is used for the Folic Acid component in cases where oral intake is not feasible or malabsorption is present.

The medicine is typically prescribed for once daily administration in adults. The overall course of use is organized into an initial treatment phase to correct the deficiency, and a subsequent maintenance phase where the dose is often reduced to sustain long-term body stores.

Administration Constraints

Contextual Factor	Procedural Instruction
Timing with Meals	Optimally taken on an empty stomach (1-2 hours before or after meals) to maximize iron absorption. May be taken with food if necessary to alleviate gastrointestinal discomfort.
Food Interference	Consumption of tea, coffee, or dairy products must be avoided for at least 2 hours surrounding the dose due to potential interference with absorption.
Tablet Integrity	Tablets must be swallowed whole and must not be crushed, broken, or chewed to preserve the intended drug release profile.

Specific dosage rules apply for certain populations. For instance, the maintenance dose for the Folic Acid component is set at 0.8 mg once daily in pregnant or lactating persons.

Recent Clinical Evidence

Research evidence / Overview of studies for Ferikind

Evidence for Use in Iron Deficiency Anemia (IDA)

The combination of Ferrous Ascorbate and Folic Acid was studied in research exploring Iron Deficiency Anemia (IDA). This evidence primarily consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews. Studies compare the combination against other oral iron supplements or control groups, examining adults and children diagnosed with nutritional anemia. Researchers monitored changes in key hematological biomarkers, including Hemoglobin ( Hb) levels and Serum Ferritin. The evidence contributes to understanding symptom patterns associated with observed changes in iron stores over short follow-up periods.

The use of oral iron and folate is reflected in global health guidelines. However, comparative evidence for Ferrous Ascorbate against other iron salts findings were heterogeneous. Follow-up durations were typically limited to 4 to 12 weeks, meaning there is limited information on the sustained maintenance of healthy iron and Hb levels after the initial period of study.

Evidence for Nutritional Support During Pregnancy

The combination was evaluated in research exploring nutritional support during pregnancy, a period associated with increased iron and folate requirements. The evidence base here consists of large-scale RCTs and meta-analyses. These studies focused on pregnant women and were studied for their potential role in the setting of nutritional deficits during gestation. Research examined maternal outcomes, such as the incidence of maternal anemia at term and iron deficiency, and infant outcomes, including Infant Birthweight and Preterm Birth (PTB) incidence.

In many systematic reviews, the evidence is often pooled for any iron and folic acid combination, which means few data directly isolate the specific role of the Ferrous Ascorbate salt. Comparative evidence regarding this specific formulation remains insufficient. Data for certain severe infant outcomes appear to remain uncertain, and the need for longer-duration studies reflects a research gap for fully establishing long-term status maintenance.

Frequently Asked Questions (FAQ)

Common questions about Ferikind (FAQ)

Q: How long does it typically take to notice any effects from Ferikind?

Regulatory documents indicate that the body's initial response to oral iron may begin to be observed in approximately one week. This is consistent with the initial rate of new blood cell production (reticulocyte count), which may peak within 7 to 10 days.

Q: What if I forget to take my Ferikind dose one day?

Official guidance describes that a forgotten dose of a once-daily iron formulation is generally recommended to be taken as soon as it is remembered, unless the time for the next scheduled dose is very near. Patient information consistently advises not to take a double dose to make up for the dose that was missed.

Q: Is Ferikind the same as other similar supplements or treatments?

Ferikind is a specific product containing a combination of Ferrous Ascorbate and Folic Acid. Official reviews of iron supplements have noted that the way the body handles the medicine—specifically its absorption and bioavailability—is influenced by the specific iron salt form used.

Q: Can people with kidney conditions use Ferikind according to official sources?

Official documentation describes that caution and professional monitoring are required for use in severe renal disorders (kidney conditions). This is because reduced kidney function may affect the management of iron levels in the body.

Q: Is it possible to take too much Ferikind?

Yes. Regulatory documents carry a prominent warning regarding the serious safety risk of Acute Iron Poisoning/Toxicity that can occur from an accidental ingestion. This concern is particularly highlighted for young children and is a serious safety concern cited in the regulatory documents.

Q: Are there any known issues with taking Ferikind and birth control pills?

Some official reports suggest that the Ascorbate component of this formulation may potentially increase the systemic levels of estrogens found in oral contraceptives. This pattern of a potential interaction is noted in official reports.

Q: Why does Ferikind have to be taken for a long period?

The duration of use, as described in official guidelines, is structured to include an initial phase to correct the existing low levels, followed by a maintenance phase to sustain long-term body stores. This comprehensive process requires a typically long course of use.

Q: Are there any specific lifestyle factors mentioned that might affect Ferikind's usefulness?

Official sources note that excessive consumption of alcohol is a relevant factor. Excessive alcohol intake is described as potentially reducing the absorption and increasing the elimination of the folic acid component of the medicine.

Q: Can Ferikind affect the results of standard blood tests?

The expected darkening or blackening of stools is documented as a known effect of oral iron. Regulatory information notes that this change in stool color may interfere with the clinical assessment of gastrointestinal bleeding (a diagnostic procedure).

Q: Is Ferikind gluten-free or suitable for people with certain dietary restrictions?

The active ingredients do not inherently contain gluten. However, the suitability of the final formulation for those with certain dietary restrictions, such as the specific gluten status, depends on the excipients (non-active ingredients) used, and information regarding specific excipients is not detailed in the core regulatory abstracts.

Q: Does the time of day I take Ferikind matter?

Official guidance for iron supplements generally suggests taking the medicine at approximately the same time every day to maintain consistent blood levels. While timing relative to meals is precisely specified, the guidance emphasizes a regular schedule.

Q: What is the recommended duration of treatment mentioned in the official guidelines?

Official guidelines define the course of use as consisting of an initial treatment phase and a maintenance phase. They do not specify a fixed total duration for all patients, as the required length is determined based on individual nutritional needs and response to therapy.

Q: Are there any warnings about taking Ferikind before surgery?

Official guidance describes that patients are often advised to temporarily stop taking oral iron supplements, such as this one, for a short period (e.g., a few days) before certain diagnostic procedures. This is typically to prevent interference with internal visualization required during tests like a colonoscopy.

Q: How quickly is Ferikind absorbed by the body according to research?

Regulatory pharmacokinetics data for the Folic Acid component indicate that it typically appears in the plasma (bloodstream) in approximately 15 to 30 minutes after an oral dose. This gives an indication of the speed at which one of the active ingredients enters the body's circulation.

Q: Does Ferikind have any effect on energy levels, based on user reports or studies?

The product is indicated for the treatment of Iron Deficiency Anemia, a condition that is commonly associated with symptoms like fatigue. Therefore, the successful replenishment of the body's stores is consistent with alleviating these deficiency-related symptoms.

Q: Does taking Ferikind make people gain or lose weight?

Weight change is not listed as a side effect on the medicine's safety label. However, some clinical reviews note that correcting an underlying nutritional deficiency with iron and folate has been observed to be associated with changes in body weight in certain individuals.

Q: Does Ferikind affect sleep patterns?

Disturbance of sleep patterns is not listed in the safety profile of the medicine. However, external research has explored the relationship between folic acid supplementation and the body's general physiological response to sleep-related conditions.

Q: Can I take other vitamins while on Ferikind?

The official interaction profile specifies known conflicts with a few key minerals (like Calcium) and certain drug classes. However, the profile does not issue a general restriction for all other common vitamins, suggesting that many may be taken together unless a specific interaction is officially documented.

Q: Why are there different strengths or versions of Ferikind available?

Official documentation describes that different strengths (e.g., tablets vs. suspension) are available to enable essential dosing adjustments for varied populations. This ensures the medicine can effectively address the range of nutritional requirements needed by both adults and children.

How should Ferikind be stored and disposed of?

How to Store and Dispose of Ferikind?

The storage and disposal requirements for Ferikind (Ferrous Ascorbate and Folic Acid) are defined by regulatory labeling to ensure product stability and public safety.

Storage Requirements

Ferikind must be kept in a cool and dry place with the temperature not exceeding 30 C. The medicine requires protection from direct sunlight, excessive heat, and moisture. It must be stored in its original container and kept tightly closed to maintain product integrity.

Child Safety and Disposal

It is a mandatory regulatory requirement to keep Ferikind out of the sight and reach of children due to the serious risks associated with iron ingestion. Unused or expired medication must not be thrown into household waste or discarded via wastewater (sinks or toilets). The product must be disposed of according to local regulations, typically utilizing a pharmacy-based drug take-back program.

Ferikind